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Abstruct 
Background: Middle-aged marathon runners have an increased risk of developing atrial fibrillation 
(AF). A previous study described that repetitive marathon running was associated with left atrial 
(LA) dysfunction. However, whether this change is common in marathon runners and which 
runners are at risk of LA dysfunction remain unknown. The purpose of this study was to determine 
which factors could predict LA dysfunction. 
Methods and results: We prospectively examined 12 healthy amateur volunteers (9 males, 31±8 
years old) who participated in a full marathon. All echocardiographic measurements and speckle-
tracking echocardiography were performed before and after the marathon. The endpoint was 
defined as reduced LA reservoir strain one day after the marathon (non-responder group). Seven 
participants were in the non-responder group. Age (35±9 vs. 26±2 yrs., p=0.020), augmentation 
index (76±12 vs. 55±8, p=0.002), and diastolic blood pressures (83±11 vs. 70±7 mmHg, 
p=0.021) in the non-responder group were significantly higher compared with the responder 
group. In multivariate linear regression analysis, only the augmentation index was an independent 
predictor of reduced LA reservoir function after the marathon (β=-0.646, p=0.023). 
Conclusion: The augmentation index was a predictive marker for reduction in LA reservoir 
function after a marathon in healthy amateur volunteers. 






































































Marathon running is becoming popular worldwide. However, there is still debate whether marathon 
running itself harms the cardiovascular system, especially arrhythmia [1-4]. Several studies 
reported that marathon runners have an increased risk of developing atrial fibrillation (AF) at 
middle age [3,5]. A major contributing factor for AF was left atrial (LA) structural and functional 
abnormality. Hence, it has been shown that marathon running is associated with LA remodeling. 
Furthermore, LA functional response to marathons has received attention in recent years [6]. LA 
function, especially LA reservoir function, is an early indicator of LA functional impairment and 
can provide information about LA myocardial structural and functional substrate [7,8]. Recently, 
LA strain analysis by 2-dimensional (2D) speckle-tracking echocardiography has been used as a 
sensitive marker of LA functional abnormalities even in the absence of LA geometrical changes 
[9,10]. Some studies have shown that athletic marathon runners have reduced LA function 
compared with sedentary individuals [11,12]. Repetitive marathon running may lead to 
decompensatory changes in the mechanical functions of the atrium, and a better understanding of 
the LA function after the marathon can be clinically relevant to the prognosis of marathon-induced 
AF. However, LA responses may vary between individuals, and the characteristics of reduced LA 
function is not well unknown. Thus, the aim of this study was to investigate the incidence, time 
course, and clinical predictors of LA dysfunction in a prospective group of healthy amateur runners. 
Materials and methods 
Study Participants 
We enrolled 12 healthy volunteers who participated in the 2017 Tokushima Full Marathon. All 




































































at the time of echocardiography; 3) absence of anemia defined by periodic health 
examination; 4) technically adequate 2D and Doppler echocardiograms; and 5) completed the 
marathon. The Institutional Review Board of the University of Tokushima approved the study 
protocol, and written informed consent was obtained from all participants. 
Data acquisition 
All participants filled out a personal questionnaire about marathons, such as amount of training and 
past marathon participation. We also measured body mass index (BMI), blood pressure (BP), and 
augmentation index (AI). Radial AI, a marker of arterial stiffness, was measured using HEM-
9010AI (Omron Healthcare Co., Ltd., Kyoto, Japan). Immediately after measuring BP via the upper 
arm, the left radial arterial waveform was obtained using the tonometric method. Radial AI was 
calculated as follows: (Second peak systolic BP − diastolic BP) / (first peak systolic BP − diastolic 
BP) ×100 (%). We performed echocardiographic studies at three separate time points: 1) within 1 
week prior to the marathon; 2) 1 day after completion of the marathon; and 3) 5 days after the 
marathon. The endpoint of this study was an impaired response of LA function, which we defined 
as decreased LA reservoir strain one day after the marathon. 
Standard echocardiographic assessment 
Standard transthoracic echocardiography was performed using a Vivid E95 ultrasound with an S5-
1 transducer (GE Healthcare, Waukesha, WI). One experienced sonographer (H.Y.) performed all 
echocardiographic examinations. All measurements, except for inferior vena cava (IVC), were 
performed on the left side in the supine position, at the end of expiration to avoid respiratory 
changes. All echocardiographic measurements (2D, pulse wave Doppler, and tissue Doppler) were 




































































Cardiovascular Imaging recommendations [13]. LV diastolic functions were assessed by 
ventricular inflow, with peak early (E) and atrial (A) flow velocities. Tissue Doppler imaging of 
septal and mitral lateral annulus were measured, and an average e' value was used. LV end-diastolic 
volume (LVEDV), LV end-systolic volume (LVESV), left atrial volume (LAV) and were 
calculated by the biplane Simpson disk method using 2D images and indexed to the body surface 
area (BSA). We measured LAVi at three stages; maximum LAVi (Vmax; at the end of ventricular 
systole just before opening the mitral valve), minimum LAVi (Vmin; at the end of ventricular 
diastole just before closing the mitral valve), and atrial volume before contraction (VpreA). 
2D strain echocardiography 
LV and LA 2D speckle-tracking echocardiography was analyzed offline using EchoPAC ver.201 
(GE Medical). All images were optimized to guarantee optimal endocardial delineation. LV global 
longitudinal strain (GLS) was obtained by averaging all segmental strain values from the apical 4-
chamber, 2-chamber, and long-axis views. LA strain was applied to the LA myocardium in apical 
4- and 2-chamber views; the software divided the atrial wall into 12 segments, and the average was
calculated for analysis. The regions of interest for LA were manually determined by tracing 
around the endocardial surface and adjusted to the thickness of the LA wall. The cardiac cycle was 
defined using the onset of the P wave in electrocardiography [14]. Strain parameters before and 
after the marathon are shown in Figure 1. The peak negative strain during atrial systole represents 
atrial contraction (LAS pump). The sum of the absolute values of negative and positive strain peaks 
(LAS cond) represent the atrial reservoir strain (LAS res) [15]. To interobserver variability analysis, 
another sonographer (M.S), who blinded to previously obtained data, measured LA reservoir strain 
of all participants. An experienced observer calculated strain values twice with a time interval of 





































































Continuous variables are presented as mean ± SD and categorical variables as frequency. The 
Fisher exact test was used to compare categorical variables. Characteristics of the three times of 
echocardiographic measurements were compared by repeated measure analysis of ANOVA. A 
paired Student t test was used in Table 3 to compare responder and non-responder groups. Non-
responder was defined as subjects showing decreased LAS res after the marathon, and those 
without decreased LAS classified as responder group. Linear regression analysis was used to 
evaluate the association between several potential values and change of LAS res before and after 
the marathon (ΔLAS res). ΔLAS res was calculated as follows: (LAS res after the marathon − LAS
res before the marathon) / LAS res after the marathon ×100 (%). All identified variables (p<0.10 
in the univariate model) were entered in stepwise manner into a multivariate model to determine 
predictors to ΔLAS res. We checked for collinearity between the independent variables and ΔLAS 
res using Pearson’s correlation coefficient. Area under the receiver operating characteristic (ROC) 
curve was used to describe the prognostic LA non-responders after the marathon. Sensitivity and 
specificity were calculated. Optimal cut-off values were determined by the analysis of the 
sensitivity and specificity values derived from the ROC curve data. To determine inter- and 
intraobserver variability, the interclass coefficient was used. A p-value <0.05 was considered 
statistically significant. Statistical analyses were performed using SPSS (version 25, SPSS Inc., 
IBM Corp., Armonk, NY, USA). 
Results 




































































All participants who completed the marathon were included in the final analysis. Their baseline 
characteristics are shown in Table 1. The mean age of the 12 participants was 31±8 yrs. (range: 
23-49 yrs.), and 9 (60%) of participants were male. Four participants were their first marathon, and
median values of total training, amount of running distance, and endurance training were 5 [range: 
2-15] times, 25 [range: 10-200] km, and 2 [range: 1-3] h/week, respectively. The mean systolic and
diastolic BPs were 126±15 and 78±11 mmHg. Two participants had hypertension, and one 
participant was current smoker. There were no other cardiovascular risk factors. The average AI 
was 67±15. Correlation between age and AI is modest (r= 0.56, p=0.05). Systolic and diastolic BPs 
were not statistical significance but seems to be correlated with AI (systolic BP; r=0.40, p=0.196; 
diastolic BP r=0.53, p=0.082). 
Impact of Marathon Running on Echocardiography 
The echocardiographic data of the participants, before and after the marathon, are listed in Table 
2. At baseline, all echocardiographic measurements were within normal range. No changes in heart
rate (HR), LV systolic function, volume and GLS were observed before and after the marathon. 
Compared to baseline measurement, average mitral A-wave velocity increased one day after the 
marathon, resulting in decreased E/A. Mitral A-wave velocity returned to baseline 5 days after the 
marathon. LAVi max (20±2 vs. 26±5 ml, p<0.001), preA (14±2 vs. 18±3 ml, p<0.001), and min 
(10±3 vs. 15±3 ml, p<0.001) increased one day after the marathon; and returned to normal 5 days 
later (Figure 2A). Averaged LA functions showed no statistical differences between before and 
after the marathon (Figure 2B). 




































































Figure 3 shows multipoint LAVi max and LA res at baseline and post marathon. LAVi max 
increased after the marathon in all participants, whether LAS res increased or not. Seven 
participants had decreased LAS res after the marathon. Based on LA response, we divided them 
into two groups; non-responder group and responder group. The characteristics and 
echocardiographic data at baseline are listed in Table 3. Age (35±9 vs. 26±2 yrs., p=0.020), AI 
(76±12 vs. 55±8, p=0.002) and diastolic BP (83±11 vs. 70±7 mmHg, p=0.021) in the non-responder 
group were significantly higher than those in the responder group. No significant differences were 
observed with regard to marathon training data. At baseline, LAVi pre A and LAVi min in non-
responder group were significantly greater compared with responder group. After the marathon, 
the non-responders had significantly lower LAS cond compared to the non-responders. LAS pump 
was no significantly between two groups. LAS pump was positively correlated with A-wave 
velocity 1 day after marathon (r=0.58, p=0.046). To determine the independent predictors of ΔLAS 
res, we performed multivariate linear regression analysis of prediction of clinical and 
echocardiographic variables with ΔLAS res. The univariate and multivariate analysis is presented 
in Table 4. In a stepwise multivariate model, AI was the only independent predictor of ΔLAS res. 
In Figure 4, ΔLAS res showed statistically a negative correlation with AI (r= -0.65, p=0.023). By 
receiver operating characteristic curve analysis, AI ≤60 can predict the LA responders, with 86% 
sensitivity and 80% specificity. Interobserver and intraobserver variability were good for LA res. 
Intraclass correlation coefficients were 0.96 (P < .001) and 0.96 (P < .001), respectively. 
Discussion 
Even in healthy volunteers, marathon running can transiently cause atrial burden. In the present 
study, echocardiographic LA parameters were transiently affected by marathon running, and LA 




































































of arterial stiffness, can predict reduced LA reservoir function after marathon running. These 
results suggest that individuals, who have atherosclerotic factors including high AI, can be 
clinically relevant to marathon-induced LA dysfunction and lead to the AF. 
LA remodeling and marathon-induced atrial fibrillation 
Previous studies reported that professional athletes have an increased risk of developing AF in 
middle age [1,2,4,16,17]. Calvo et al. [18] analyzed 182 consecutive patients who underwent AF 
ablations, and 39% of spontaneous AF patients were classified as endurance athletes (endurance 
sport activity >3 hours per week). In professional athletes, LA functional was decreased and LA 
volume was greater compared to age-matched healthy sedentary men [19]. Furthermore, cardiac 
dimensions do not completely regress to normal levels even several years after the athlete has 
retired [20]. In animals, high level exercise training has been associated with atrial enlargement, 
fibrosis, and propensity for high-grade arrhythmias, which reverse after the cessation of training 
[21,22]. LA remodeling may be a physiologic adaptation to volume overload, permitting a greater 
volume delivery and increased cardiac output. Cardiac response returned during few days, but with 
this recurrent stretch of LA geometry, some individuals may be prone to the development of 
chronic structural changes in response to the recurrent volume overload and excessive cardiac 
strain [23-25]. These repetitive burdens are might predispose to serious arrhythmias such as AF. 
According to these results, marathon-induced LA remodeling seems to be one of the major 
contributing factors for developing AF [26,27]. In amateur runners, LA remodeling is not clear 
compared to athletes at rest. Wilhelm et al. [28] reported that individuals with more endurance 
training showed greater LA volumes. Furthermore, Brugger et al. [29] showed LAVi min, VpreA 




































































high training group. In our study, LAVi of all the participants transiently increased after the 
marathon. The results of this study are consistent with previous studies. 
Impact of Marathon Running on LA function 
In our data, while averaged LA reservoir strain was not significantly different between before and 
after the marathon, we found that LA functional response varied among individuals. Hence, we 
classified two groups based on LA functional response post marathon; there were 7 (58%) subjects 
classified non-responder group, and LA conduit strain after marathon was significantly difference 
between two groups. Previous studies utilizing speckle-tracking analysis, LV function parameters 
after marathon running were previously reported [29,30]. These studies suggest that speckle-
tracking analysis is a valuable tool to detect structural and functional abnormalities in 
cardiovascular disease, including AF. In addition, previous studies have shown that professional 
athletes had reduced LA reservoir function [11,12]. LA reservoir function is the first to be affected 
when ventricular afterload is increased, or in cases with atrial burden [31]. Furthermore, some 
studies reported LA reservoir strain and LA conduit strain correlated closely with exercise capacity 
[32]. This suggests that LA conduit reflect of early LA remodeling causing increased stiffness and 
decreased elastance. LA strain is affected early and consistently in the course of LA remodeling, 
hense it been proposed as an early marker of LA functional decline. Based on these results, it is 
assumed that decreased LA reservoir function after a marathon may related to occult LA 
dysfunction. 
Prediction of LA Functional Response after the Marathon 
As we already mentioned, LA dysfunction may occur even before dilatation of LA. Previous 



































































for LA dimensions [33,34]. These discrepancies between anatomy and function support the idea 
that LA strain can represent an early marker of LA dysfunction and clinical deterioration, offering 
additional prognostic value compared with LA dimensions. AI is a useful marker of atherosclerotic 
risk stratification, such as hypertension. Hypertension is one of the major contributing factor for 
AF [35]. A previous study reported that increase in AI was a potential risk for AF [36]. Individuals 
with high AI cannot adapt to changes in blood pressure smoothly, thus increasing the burden on 
the entire cardiovascular system. We suspect that repetitive overloading of LA stress, from events 
such as marathon running, could lead to decompensatory changes in mechanical function of the 
atrium. Our results indicate that an increase in AI is a useful marker for predicting reduced LA 
reservoir function after a marathon. Marathon runners, who have atherosclerotic factors, have a 
risk of decreased LA function after a marathon. This in turn leads to atrial enlargement, which 
eventually may increase the risk of AF onset. Therefore, we recommend that such individuals 
should take care of the cardiovascular risk factors and/or exercise with moderation. 
Limitations 
This study presents several limitations. First, the small number of participants included in the study 
limited its statistical power. We may explained the notion of chance variation．The results from 
our study can be interpreted as a preliminary study for future studies involving more subjects. 
Second, we observed echocardiographic changes across a time frame of days, not hours after the 
marathon. Third, there is a lack of long-time follow up data, but we have no onset of AF in this 
cohort beyond 20 months. Last, we analyzed relatively young volunteers with few atherosclerotic 
factors. Other imaging modalities have not been done. Some papers had demonstrated the 
relationship between marathon runners greater than 50 years of age and CAD risk by using 





































































Unfortunately, we found it unreasonable to conduct CT on healthy young volunteers with no known 
coronary risk factors. To evaluate our theories, we suggest that further studies be conducted with 
an older population, and presumably with more atherosclerotic factors. 
Conclusion 
In healthy amateur volunteers who ran a full marathon, high AI can predict LA reservoir 
dysfunction after marathon running. It suggests that marathon runners, who have atherosclerotic 
factors, can be clinically relevant to occult LA dysfunction and lead to the onset of AF. Larger 
validation studies are needed to confirm these findings. 
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Figure 1. Example of speckle-tracking strain analysis of the left atrium before and one day after 
the marathon. A representative case of non-response subject before (A) and one day after the 
marathon (B). The other is a representative case of response subject before (C) and one day after 
the marathon (D). The region of interest on the LA myocardium in the apical four-and two-chamber 
views are illustrated by the multicolored curve superimposed on the LA at the left of the figure. 
The average LA strain from the 12 myocardial segments imaged in this example is displayed by 
the dotted white curve to the right of the figure. 
Figure2. Impact of marathon running on LA volume index (LAVi) and strain. All LAVi increased 
one day after the marathon; returned to normal 5 days later (A). LA strain showed no significant 
differences between before and one day after the marathon (B). 
Figure3. Multipoint LAVi max and LAS res at baseline and post marathon in non-response (A) 
and response (B) group. 



































































B: One day after a marathon A：Before marathon
LAS pump LAS pump
LAS cond LAS cond
LAS res LAS res
Figure
D: One day after a marathon C：Before marathon
LAS pump
LAS pump
LAS cond LAS cond
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Table1. Characteristics of 12 amateur runner participating in full marathon 
M=Male; F=Female; BMI = body mass index; AI= Augmentation index 




















A 20s M 17.6 105/70 60.0 0 <5 10 2 
B 20s M 25.9 131/77 46.0 1-5 <5 20 1 
C 20s M 19.3 121/66 66.0 0 >20 200 2 
D 20s M 22.1 133/78 73.0 0 <5 <10 <1 
E 20s M 23.7 122/72 57.0 1-5 <5 10 <1 
F 30s M 22.2 120/74 64.0 1-5 <5 10 <1 
G 30s M 25.8 129/76 57.0 1-5 10 50 3 
H 40s M 23.8 144/80 82.0 1-5 <5 30 2 
I 40s M 24.7 145/76 92.0 ≧6 >15 200 2 
J 20s F 20.1 110/66 83.0 1-5 <5 20 1 
K 20s F 19.1 106/62 57.0 1-5 >15 200 2 
L 20s F 19.7 127/64 80.0 0 5 30 2 
Table
* 
Table2. Echocardiographic measurement on before- and after-marathon 
LV = left ventricle; LVEDVi = left ventricle end diastolic volume index; LVESVi = left 
ventricle end systolic volume index; LVEF = left ventricle ejection fraction; 
IVC=inferior vena cava; TRPG = tricuspid regurgitation pressure gradient 
Data are expressed in mean ±SD 
* p < 0.05 versus baseline and †p < 0.05 versus 1 day after marathon by ANOVA 
analysis.  
Bold values signify p < 0.05 by ANOVA between the 3 groups. 
Before 
marathon 
1 day after 
marathon 
5 days after 
Marathon 
P value 
67±6 72±10 71±9 0.177 
68±13 70±14 69±14 0.513 
65±9 66±9 65±8 0.624 
23±3 24±4 23±4 0.574 
65±2 64±2 64±3 0.602 
17±4 16±6 18±4 0.417 
76±10 74±15 80±14 0.215 
41±10* 53±10*† 44±11† 0.001 
1.90±0.5* 1.48±0.3*† 1.91±0.5† 0.001 
13.7±3.1* 13.4±2.7*† 14.2±3.0† 0.036 
5.6±1.3 5.8±1.4 5.9±1.5 0.912 
18.2±3.0 18.8±4.3 18.9±5.4 0.412 
Heart rate, beats/min 








e’ average, cm/s 
E/e’ 
TRPG 
LV global longitudinal strain, % 19.3±1.9 19.2±1.9 19.6±1.8 0.058 
† 







35±9 26±2 0.020 
5/2 4/1 0.380 
22.3±2.5 21.4±3.4 0.300 
131±16 120±12 0.111 
83±11 70±7 0.021 
76±12 55±8 0.002 
5±4 8±7 0.245 
50±68 88±102 0.246 
1.9±1.5 1.6±1.3 0.380 
2.4±2.0 1.6±1.5 0.221 
323±39 308±49 0.298 
69±7 64±4 0.079 
64±8 61±9 0.291 
67±9 63±9 0.231 
25±2 22±3 0.130 
65±3 65±3 0.339 
17±5 18±3 0.416 
72±12 78±8 0.112 
44±12 37±4 0.104 
1.7±0.5 2.1±0.5 0.107 
12.9±3.4 15.0±2.5 0.125 
5.9±1.5 5.3±0.8 0.202 
19±2 20±3 0.336 
11.9±2.6 10.8±2.7 0.249 
21±2 20±2 0.112 
15±2 13±2 0.043 
11±3 9±1 0.041 
37±5 36±4 0.448 
23±6 25±4 0.235 
Age, yrs 
Male/Female 
Body mass index, kg/m2 
Systolic blood pressure, mmHg 
Diastolic blood pressure, mmHg 
Augmentation index 
Total training, time 
Total running distance, km 
Endurance training, h/week 
Former marathon participations, time 
Marathon race time, min 
Echocardiography 
Heart rate, beats/min 








e’ average, cm/s 
E/e’ 
LV global longitudinal strain, % 
LA global longitudinal strain, % LAVi 
max (before marathon), ml/m2 LAVi 
preA (before marathon), ml/m2 
LAVi min (before marathon), ml/m2 
LAS res (before marathon), % 
LAS cond (before marathon), % 
LAS pump (before marathon), % 14±3 11±2 0.072 
LA = left atrial; LV = left ventricle; LVEF = left ventricle ejection fraction; LVEDVi = 
left ventricle end diastolic volume index; LVESVi = left ventricle end systolic volume 
index; IVC=inferior vena cava; TRPG = tricuspid regurgitation pressure gradient; 
LAVi= left atrial volume index; LAS= left atrial strain 
Data are expressed in mean ±SD, Bold values signify p < 0.05 by t-test analysis 
28±4 25±5 0.279 
19±3 16±3 0.062 
16±3 13±4 0.060 
33±4 43±5 <0.001 
20±5 31±4 0.001 
LAVi max (1 day after marathon), ml/m2 
LAVi preA (1 day after marathon), ml/m2 
LAVi min (1 day after marathon), ml/m2 
LAS res (1 day after marathon), % 
LAS cond (1 day after marathon), % 
LAS pump (1 day after marathon), % 13±2 12±2 0.347 
Table4. Uni- and multivariate linear regression analysis to demonstrate independent 
predictors of ΔLAS res (%) 
Univariate Multivariate (stepwise) 





-0.706 0.090 † † † 

































Body mass index  
Systolic blood pressure  
Diastolic blood pressure  
Augmentation index  
Total training 
Total running distance 
Endurance training  
Former marathon participations 
Marathon race time  
Heart rate  








e’ average  
E/e’ 
TRPG  
LV global longitudinal strain 
LAVi max  
LAVi preA  
LAVi min 
LAS res  
LAS cond 
LAS pump -1.543 0.369 
LA = left atrial; LV = left ventricle; LVEF = left ventricle ejection fraction; LVEDVi = 
left ventricle end diastolic volume index; LVESVi = left ventricle end systolic volume 
index; IVC=inferior vena cava; TRPG = tricuspid regurgitation pressure gradient; 
LAVi= left atrial volume index; LAS= left atrial strain 
† Eliminated though the stepwise method 
